Annink, Kim V.
de Vries, Linda S.
Groenendaal, Floris
Vijlbrief, Daniel C.
Weeke, Lauren C.
Roehr, Charles C.
Lequin, Maarten
Reiss, Irwin
Govaert, Paul
Benders, Manon J. N. L.
Dudink, Jeroen
Article History
First Online: 26 March 2020
Competing interests
: F.G. is the founder of 2-iminobiotin and medicolegal expert in cases of perinatal asphyxia. F.G. also received grant support from Neurophyxia. L.S.d.V. received lecture fees for lectures from Genesis Research Trust for the ultrasound course in Imperial College London and at the brain monitoring meeting in Cork in 2017. C.C.R. has received lecture fees from various pharmaceutical and medical devices companies on matters unrelated to the topic in this supplement, and received grant funding from Chiesi Pharamceutical Grant for investigating specific pharmacodynamics in newborn infants, also unrelated to the manuscripts in this supplement. The other authors have no conflict of interest to declare.
: The Ethical Committee of the University Medical Center Utrecht approved this retrospective study and waived the requirement to obtain written informed consent for this study.